Published in J Epidemiol Community Health on June 01, 2003
Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework. BMJ (2008) 3.80
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med (2008) 3.02
Deprivation and quality of primary care services: evidence for persistence of the inverse care law from the UK Quality and Outcomes Framework. J Epidemiol Community Health (2006) 2.50
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
The contribution of general practice and the general practitioner to NHS patients. J R Soc Med (2006) 1.88
Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer (2009) 1.74
The quality and outcomes framework of the GMS contract: a quiet evolution for 2006. Br J Gen Pract (2006) 1.72
Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005-2008). Soc Sci Med (2010) 1.59
Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland. Br J Cancer (2014) 1.45
Uptake in cancer screening programmes: a priority in cancer control. Br J Cancer (2009) 1.43
Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types. Br J Cancer (2014) 1.33
The Quality and Outcomes Framework: too early for a final verdict. Br J Gen Pract (2007) 1.31
Ethnic disparities in knowledge of cancer screening programmes in the UK. J Med Screen (2010) 1.18
Coverage of Jade Goody's cervical cancer in UK newspapers: a missed opportunity for health promotion? BMC Public Health (2010) 1.15
Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women. J Med Screen (2008) 1.02
Utilisation of preventative health check-ups in the UK: findings from individual-level repeated cross-sectional data from 1992 to 2008. BMJ Open (2013) 1.01
Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006. Br J Cancer (2011) 1.00
Association between human papillomavirus vaccine status and other cervical cancer risk factors. Vaccine (2014) 0.99
The association between socio-demographic characteristics and adherence to breast and colorectal cancer screening: analysis of large sub populations. BMC Cancer (2011) 0.98
What is the 'problem' that outreach work seeks to address and how might it be tackled? Seeking theory in a primary health prevention programme. BMC Health Serv Res (2011) 0.98
Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health (2009) 0.97
How Financial and Reputational Incentives Can Be Used to Improve Medical Care. Health Serv Res (2015) 0.96
Future of quality measurement. BMJ (2007) 0.96
Investigating the effects of medical density on health-seeking behaviours using a multiscale approach to residential and activity spaces: results from a prospective cohort study in the Paris metropolitan area, France. Int J Health Geogr (2012) 0.92
Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study. J Fam Plann Reprod Health Care (2014) 0.92
Socioeconomic disparity in cervical cancer screening among Korean women: 1998-2010. BMC Public Health (2013) 0.91
Non-participation in population-based disease prevention programs in general practice. BMC Public Health (2012) 0.91
Barriers and facilitators to uptake of the school-based HPV vaccination programme in an ethnically diverse group of young women. J Public Health (Oxf) (2015) 0.84
Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study. BMC Health Serv Res (2007) 0.84
Cervical cancer screening service utilisation in UK. Sci Rep (2013) 0.81
Socioeconomic status and cancer screening in Japanese males: Large inequlaity in middle-aged and urban residents. Environ Health Prev Med (2007) 0.80
Breast and cervical cancer screening in Great Britain: Dynamic interrelated processes. Health Econ Rev (2015) 0.77
Colposcopy attendance and deprivation: A retrospective analysis of 27,193 women in the NHS Cervical Screening Programme. Br J Cancer (2015) 0.76
Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap? J Med Screen (2015) 0.76
Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study. BMJ Open (2016) 0.75
Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour. BMJ Open (2015) 0.75
Changes in the magnitude of social inequality in the uptake of cervical cancer screening in Taiwan, a country implementing a population-based organized screening program. Int J Equity Health (2014) 0.75
Geographical Disparities in the Health of Iranian Women: Health Outcomes, Behaviors, and Health-care Access Indicators. Int J Prev Med (2017) 0.75
Assessment of trends in socioeconomic inequalities in cancer screening services in Korea, 1998-2012. Int J Equity Health (2016) 0.75
Incentivised chronic disease management and the inverse equity hypothesis: findings from a longitudinal analysis of Scottish primary care practice-level data. BMC Med (2017) 0.75
Can pay for performance improve the quality of primary care? BMJ (2016) 0.75
Women's perspectives on human papillomavirus self-sampling in the context of the UK cervical screening programme. Health Expect (2017) 0.75
Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet (2001) 13.31
Measuring the quality of medical care. A clinical method. N Engl J Med (1976) 11.68
Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ (1994) 9.81
Health inequalities and the health of the poor: what do we know? What can we do? Bull World Health Organ (2000) 8.23
Explaining trends in inequities: evidence from Brazilian child health studies. Lancet (2000) 7.04
Explaining outputs of primary health care: population and practice factors. BMJ (1991) 5.61
Some international comparisons of mortality amenable to medical intervention. Br Med J (Clin Res Ed) (1986) 5.33
Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ (1999) 4.66
Inequalities in health: ten years and little further on. Lancet (1990) 3.77
Do interventions that improve immunisation uptake also reduce social inequalities in uptake? BMJ (1994) 2.80
Changing patterns of cervical cancer rates. Br Med J (Clin Res Ed) (1983) 2.73
Change in general practice and its effects on service provision in areas with different socioeconomic characteristics. BMJ (1995) 2.60
Predictions of cervical cancer incidence and mortality in England and Wales. Lancet (1986) 2.36
Inequalities in health in the city of Bristol: a preliminary review of statistical evidence. Int J Health Serv (1985) 2.17
Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands. Soc Sci Med (1988) 2.11
Survey of population coverage in cervical cancer screening in the Oxford region. J R Coll Gen Pract (1987) 2.01
Accelerated decline in cervical cancer mortality in England and Wales. Lancet (1995) 1.95
How complete and accurate are cancer registrations notified by the National Health Service Central Register for England and Wales? J Epidemiol Community Health (2001) 1.70
Contextual variations in the meaning of health inequality. Soc Sci Med (1991) 1.42
Regional inequalities in mortality. J Epidemiol Community Health (1993) 1.25
Risk factors for invasive cervix cancer in young women. Eur J Cancer (1996) 1.19
Effect of organized screening on incidence and mortality of cervical cancer in Denmark. Cancer Res (1989) 1.19
The contribution of medical care to mortality decline: McKeown revisited. J Clin Epidemiol (1996) 1.06
Social class, marital status, and cancer of the uterine cervix in England and Wales, 1950-1983. J Epidemiol Community Health (1992) 0.93
Role of screening in reducing invasive cervical cancer registrations in England. J Med Screen (1996) 0.90
Uptake of cervical screening in general practice: effect of practice organisation, structure, and deprivation. J Med Screen (1996) 0.84
A review of cervical cancer and cervical screening: implications for nursing practice. J Adv Nurs (1995) 0.84
Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1972) 1.71
Vancomycin anaphylaxis and successful desensitization. Ann Allergy (1994) 1.64
Autonomic imbalance in asthma with special reference to beta adrenergic blockade. Adv Intern Med (1972) 1.56
Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol (1994) 1.45
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
The anatomical and biochemical basis of bronchial obstruction in asthma. Ann Intern Med (1965) 1.42
Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther (1989) 1.32
Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium. J Pharm Sci (1980) 1.28
Metabolic response to epinephrine in bronchial asthma. J Allergy (1968) 1.26
Allergy-related diseases and cancer: an inverse association. Am J Epidemiol (1985) 1.25
Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans. J Pharm Sci (1982) 1.18
Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol (1989) 1.15
IgE levels in sera of children with asthma. Pediatrics (1971) 1.15
Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions. J Epidemiol Community Health (2008) 1.15
A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis (1989) 1.14
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (1993) 1.10
Ascorbic acid-enhanced antiproliferative effect of flavonoids on squamous cell carcinoma in vitro. Anticancer Drugs (1993) 1.10
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr (1982) 1.08
Effect of hydrocortisone on immunoglobulin synthesis and secretion by human peripheral lymphocytes in vitro. Int Arch Allergy Appl Immunol (1972) 1.06
Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol (1999) 1.03
Quercetin: an inhibitor of antigen-induced human basophil histamine release. J Immunol (1981) 1.03
Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J Pharmacokinet Biopharm (1994) 1.02
Role of calcium and calcium antagonists in airway function. Eur J Respir Dis Suppl (1983) 1.02
Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol (1984) 0.98
Effects of flavonoids and transitional metal cations on antigen-induced histamine release from human basophils. Biochem Pharmacol (1982) 0.96
Discordant allergic manifestations in monozygotic twins: genetic identity versus clinical, physiologic, and biochemical differences. J Allergy (1971) 0.95
Effect of carbohydrates on estimated hepatic blood flow. Clin Pharmacol Ther (1984) 0.95
Effects of smooth muscle calcium antagonists on human basophil histamine release. Biochem Pharmacol (1981) 0.94
Effect of adrenergic compounds, aminophylline and hydrocortisone, on in vitro immunoglobulin synthesis by normal human peripheral lymphocytes. J Allergy Clin Immunol (1973) 0.94
The effect of phentolamine on adenylate cyclase and on isoproterenol stimulation in leukocytes from asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1973) 0.93
Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone. Clin Pharmacol Ther (1991) 0.92
Regulatory role of prostaglandin E in allergic histamine release with observations on the responsiveness of basophil leukocytes and the effect of acetylsalicylic acid. J Allergy Clin Immunol (1977) 0.92
Fatal varicella in a corticosteroid-dependent asthmatic receiving troleandomycin. Allergy Proc (1990) 0.92
Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther (1992) 0.90
Newer drugs in management. Calcium antagonists. Chest (1985) 0.90
Disodium cromoglycate in bronchial asthma. Ann Intern Med (1969) 0.90
Airway smooth muscle in exercise-induced bronchospasm: some speculations. Pediatrics (1975) 0.90
Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man. J Pharmacokinet Biopharm (1992) 0.90
Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. Anticancer Drugs (1992) 0.89
A dose-response study of the bronchodilator action of azelastine in asthma. J Allergy Clin Immunol (1987) 0.87
Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (1996) 0.87
Calcium antagonists and asthma. J Allergy Clin Immunol (1985) 0.86
Naturally occurring flavonoids and human basophil histamine release. Int Arch Allergy Appl Immunol (1985) 0.86
Release of histamine from rat mast cells by lysosomal cationic proteins. Possible involvement of adenylate cyclase and adenosine triphosphatase in pharmacologic regulation. Int Arch Allergy Appl Immunol (1973) 0.85
Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett (1991) 0.85
Inhibition of reverse transcriptases by flavonoids. Antiviral Res (1989) 0.85
Flavonoid modulation of human neutrophil function. J Allergy Clin Immunol (1984) 0.85
The effects of a beta-2 selective adrenergic agonist and a beta-nonselective antagonist on theophylline clearance. J Clin Pharmacol (1987) 0.84
The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am J Surg (1989) 0.84
Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism. Life Sci (1982) 0.84
Prednisolone disposition in steroid-dependent asthmatic children. J Allergy Clin Immunol (1981) 0.84
Asthma deaths: are they preventable? N Engl Reg Allergy Proc (1988) 0.83
Reductions in cardiovascular risk in association with population screening: a 10-year longitudinal study. J Public Health (Oxf) (2007) 0.82
Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. J Allergy Clin Immunol (1990) 0.81
Increased adenosine triphosphatase in leukocytes of asthmatic children. J Clin Invest (1974) 0.81
Lymphocyte blast transformation. II. The mechanism of action of alpha adrenergic receptor effects. Int Arch Allergy Appl Immunol (1971) 0.80
Drug-induced changes of adenylate cyclase activity in cells from asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1977) 0.80
Tumor promoter-induced basophil histamine release: effect of selected flavonoids. Biochem Pharmacol (1987) 0.80
Collaborative asthma self-management. Evaluation designs. Clin Rev Allergy (1987) 0.79
Clinical conference: Severe obstructive lung disease in a 14-year-old girl with alpha-1 antitrypsin deficiency. J Allergy Clin Immunol (1976) 0.79
Inhibition by quercetin of thyroid hormone stimulation in vitro of human red blood cell Ca2+-ATPase activity. Cell Calcium (1983) 0.79
Lack of effect of atenolol on the pharmacokinetics of theophylline. Br J Clin Pharmacol (1988) 0.79
The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. J Allergy Clin Immunol (1986) 0.78
Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow. Clin Pharmacol Ther (1985) 0.77
Comparison of the effects of quercetin with those of other flavonoids on the generation and effector function of cytotoxic T lymphocytes. Immunopharmacology (1984) 0.77
Effect of flavonoids on basophil histamine release and other secretory systems. Prog Clin Biol Res (1986) 0.77
Plasma prostaglandin concentrations in allergic bronchial asthma. Int Arch Allergy Appl Immunol (1978) 0.77
The treatment of asthma--beyond bronchodilators. N Engl Reg Allergy Proc (1985) 0.77
Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol (1987) 0.76
The flavonoids: a brief review and study of effects on antigen-induced histamine release from human basophils. Trans Am Clin Climatol Assoc (1981) 0.76
Airway smooth muscle, asthma, and calcium ions. J Allergy Clin Immunol (1984) 0.76
Prolonged oestrogenic and mitogenic activity of tamoxifen in the ovariectomized mouse. J Endocrinol (1978) 0.76
Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med (1996) 0.76
Quercetin inhibits anaphylactic contraction of guinea pig ileum smooth muscle. Int Arch Allergy Appl Immunol (1983) 0.76
Electrolyte and fluid appetite and balance in male guinea-pigs: effects of stilboestrol treatment and renal function tests. J Endocrinol (1974) 0.76
Asthma, inhaled allergens, and washing the cat. Am Rev Respir Dis (1991) 0.75
Efficacy and safety of cetirizine therapy in perennial allergic rhinitis. Ann Allergy (1992) 0.75
An impregnating chamber and polymerization oven for preparing blocks of frozen-dried tissue embedded in methacrylate. Lab Pract (1967) 0.75
Clinical and biochemical correlations in asthma. Proc Inst Med Chic (1973) 0.75
Increased adenosine triphosphatase activity in platelets of asthmatic children. Int Arch Allergy Appl Immunol (1975) 0.75
Passage of inulin and p-aminohippuric acid through artificial membranes: implications for measurement of renal function. J Membr Biol (1975) 0.75
Effects of glucocorticosteroids on the urinary excretion of cyclic AMP and electrolytes by asthmatic children. J Allergy Clin Immunol (1974) 0.75
[Smooth muscle contraction augmenting factor produced by human mononuclear cell. II. Produce by subsets of mononuclear cells and effect on the smooth muscle of the trachea]. Arerugi (1983) 0.75
Asthma: the promise of drug therapy. Med Times (1975) 0.75
Asthma and the use of CNS depressants: gender differences. J Asthma (1992) 0.75
The biochemical basis for the modulation of allergic reactions by drugs. Pediatr Clin North Am (1975) 0.75
Prostaglandin E and mitogenic stimulation of human lymphocytes in serum-free medium. Prostaglandins (1978) 0.75
Administration of ketamine or Innovar by the microdrip technic: a double blind study. Anesth Analg (1977) 0.75
A rational approach to asthma therapy. Postgrad Med (1980) 0.75
Preparation of rodent kidney for light microscopy by freeze-drying and embedding in water-soluble methacrylate. J R Microsc Soc (1967) 0.75
Prednisolone disposition in steroid-dependent asthmatics. J Allergy Clin Immunol (1980) 0.75
A statement on the question of allergy to fluoride as used in the fluoridation of community water supplies. J Allergy (1971) 0.75
[Smooth muscle contraction augmenting factor produced by human mononuclear cell]. Arerugi (1983) 0.75
The molecular configuration of inulin: implications for ultrafiltration theory and glomerular permeability. J Membr Biol (1977) 0.75
Positive lupus erythematosus preparations and penicillin sensitivity. J Allergy Clin Immunol (1971) 0.75
Calcium ions, airway function, and asthma. Asian Pac J Allergy Immunol (1983) 0.75
A study of three untoward reactions to dextran. J Allergy (1970) 0.75